New stock news | Aikobai submits an application to the Hong Kong Stock Exchange, focusing on meeting the medical needs of respiratory and pediatric diseases.

According to the China Fortune APP, on September 15, the Shanghai Aikebai Biological Medical Technology Co., Ltd. (referred to as "Aikebai") submitted an application for listing on the main board of the Hong Kong Stock Exchange, with JPMorgan Chase and CITIC Securities as joint sponsors.